Vasoactivity to and Endogenous Release of Vascular Endothelial Growth Factor in the in vitro Perfused Human Placental Lobule from Pregnancies Complicated by Preeclampsia

Placenta

Volumn 29, Issue 11, 2008, Pages 950-955

  Brownbill, P ^a   Mills, T A ^a   Soydemir, D F ^a   Sibley, C P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cytokines; Fetoplacental circulation; Preeclampsia; Pregnancy; Vascular endothelial growth factor; Vasculature

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETOPLACENTAL UNIT; FETUS CIRCULATION; HUMAN; IN VITRO STUDY; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; VASODILATATION;

FEMALE; HUMANS; MEMBRANE PROTEINS; PERFUSION; PLACENTA; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATION; VEINS;

EID: 54849441409     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.08.020     Document Type: Article

References (40)

1. Thornburg K.L. Fetal response to intrauterine stress. Ceba Found Symp 156 (1991) 17-29
2. Severi F.M., Rizzo G., Bocchi C., D'Antona D., Verzuri M.S., and Arduini D. Intrauterine growth retardation and fetal cardiac function. Fetal Diagn Ther 15 (2000) 8-19
3. Poston L. The control of blood flow to the placenta. Exp Physiol 82 (1997) 377-387
4. Brownbill P., Bell N.J., Woods R.J., Lowry P.J., Page N.M., and Sibley C.P. Neurokinin B is a paracrine vasodilator in the human fetal placental circulation. J Clin Endocrinol Metab 88 (2003) 2164-2170
5. Benoit C., Zavecz J., and Wang Y. Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas. Placenta 28 (2007) 498-504
6. Read M.A., Boura A.L., and Walters W.A. Effects of variation in oxygen tension on responses of the human fetoplacental vasculature to vasoactive agents in vitro. Placenta 16 (1995) 667-678
7. Trudinger B.J., Giles W.B., Cook C.M., Bombardieri J., and Collins L. Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol 92 (1985) 23-30
8. Myatt L., Eis A.L., Brockman D.E., Greer I.A., and Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod 12 (1997) 167-172
9. Holcberg G., Huleihel M., Sapir O., Katz M., Tsadkin M., Furman B., et al. Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol 94 (2001) 69-72
10. Okamura K., Murotsuki J., Watanabe T., Tanigawara S., Uehara M., Yano M., et al. Relation between fetal blood gas levels and the outcome of babies in severe preeclampsia. Tohoku J Exp Med 167 (1992) 279-285
11. Lyall F., Young A., and Greer I.A. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 173 (1995) 714-718
12. Trudinger B., Wang J., Athayde N., Beutler L., and Wang X. Association of umbilical placental vascular disease with fetal acute inflammatory cytokine responses. J Soc Gynecol Investig 9 (2002) 152-157
13. Roberts J.M., Pearson G.D., Cutler J.A., and Lindheimer M.D. Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertens Pregnancy 22 (2003) 109-127
14. Kofinas A.D., Penry M., Nelson L.H., Meis P.J., and Swain M. Uterine and umbilical artery flow velocity waveform analysis in pregnancies complicated by chronic hypertension or preeclampsia. South Med J 83 (1990) 150-155
15. Ahmed A., Li X.F., Dunk C., Whittle M.J., Rushton D.I., and Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12 (1995) 235-243
16. Lash G.E., Taylor C.M., Trew A.J., Cooper S., Anthony F.W., Wheeler T., et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors 20 (2002) 189-196
17. Brownbill P., McKeeman G.C., Brockelsby J.C., Crocker I.P., and Sibley C.P. Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology 148 (2007) 4734-4744
18. Szukiewicz D., Szewczyk G., Watroba M., Kurowska E., and Maslinski S. Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecol Obstet Invest 59 (2005) 102-107
19. Baker P.N., Krasnow J., Roberts J.M., and Yeo K.T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 86 (1995) 815-821
20. Brockelsby J.C. Increased circulating levels of vascular endothelial growth factor in preeclamsia. Hypertens Pregnancy 17 (1998) 283-290
21. Lyall F., Greer I.A., Boswell F., and Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 104 (1997) 223-228
22. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
23. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
24. Lee E.S., Oh M.J., Jung J.W., Lim J.E., Seol H.J., Lee K.J., et al. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci 22 (2007) 94-98
25. Lyall F., Young A., Boswell F., Kingdom J.C., and Greer I.A. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 18 (1997) 269-276
26. Myatt L. Role of placenta in preeclampsia. Endocrine 19 (2002) 103-111
27. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 (1996) 4604-4613
28. Brownbill P., and Sibley C.P. Regulation of transplacental water transfer: the role of fetoplacental venous tone. Placenta 27 (2006) 560-567
29. Schneider H., Panigel M., and Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114 (1972) 822-828
30. Wilcox M.A., Johnson I.R., Maynard P.V., Smith S.J., and Chilvers C.E. The individualised birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone. Br J Obstet Gynaecol 100 (1993) 342-347
31. Illsley N.P., Fox H., Van der Veen F., Chawner L., and Penfold P. Human placental ultrastructure after in vitro dual perfusion. Placenta 6 (1985) 23-32
32. Dancis J. The transfer of nutrients across the perfused human placenta. Adv Nutr Res 8 (1990) 1-10
33. Walters W.A., and Boura A.L. Regulation of fetal vascular tone in the human placenta. Reprod Fertil Dev 3 (1991) 475-481
34. Schneider H. Techniques: in vitro perfusion of human placenta. In: Sastry B.V.R. (Ed). Placental toxicology (1995), CRC, London 1-25
35. Schneider H. Placental oxygen consumption. Part II: In vitro studies - a review. Placenta 21 (2000) S38-S44
36. Achen M.G., Gad J.M., Stacker S.A., and Wilks A.F. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors 15 (1997) 69-80
37. Ahmed A., Dunk C., Ahmad S., and Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - a review. Placenta 21 Suppl A (2000) S16-S24
38. Green C.J., Lichtlen P., Huynh N.T., Yanovsky M., Laderoute K.R., Schaffner W., et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61 (2001) 2696-2703
39. Knock G.A., Sullivan M.H., McCarthy A., Elder M.G., Polak J.M., and Wharton J. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther 271 (1994) 1007-1015
40. Ong S.S., Crocker I.P., Warren A.Y., and Baker P.N. Functional characteristics of chorionic plate placental arteries from normal pregnant women and women with pre-eclampsia. Hypertens Pregnancy 21 (2002) 175-183